Jade Biosciences, Inc. - JBIO

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$1.665B
QoQ value delta ($000)
+$949.3M (+132.61%)
Implied price effect (QoQ)
+52.58%
Shares
Total shares
76,113,811
QoQ shares delta
+26,186,049 (+52.45%)
Total shares held by funds (by quarter)

Market chart (JBIO)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 156 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
FMR LLC 202,799 9,126,877 0.01%
Jupiter Topco LLC 139,369 6,273,262 0.06%
Fairmount Funds Management LLC 101,178 4,553,494 6.69%
RA CAPITAL MANAGEMENT, L.P. 81,571 3,671,083 0.71%
Venrock Adviser, LLC 71,556 3,220,364 2.17%
Bellevue Group AG 67,948 3,057,996 1.43%
Paradigm Biocapital Advisors LP 63,491 2,857,405 1.19%
BlackRock, Inc. 62,248 2,801,451 0.0%
FRANKLIN RESOURCES INC 62,040 2,792,080 0.01%
STATE STREET CORP 51,890 2,335,285 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 49,878 2,244,773 0.0%
JANUS HENDERSON GROUP PLC 43,557 3,105,669 0.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 42,458 1,910,812 0.06%
Polar Capital Holdings Plc 41,039 1,846,982 0.1%
Avidity Partners Management LP 37,789 1,700,708 6.05%
Remedium Capital Partners, LLC 35,057 1,577,750 7.76%
Soleus Capital Management, L.P. 34,456 1,550,690 1.19%
JPMORGAN CHASE & CO 32,613 1,475,079 0.0%
BAKER BROS. ADVISORS LP 27,340 1,230,426 0.14%
Logos Global Management LP 24,997 1,125,000 1.08%
Versant Venture Management, LLC 22,037 991,783 13.55%
ACORN CAPITAL ADVISORS, LLC 21,925 986,760 5.98%
GEODE CAPITAL MANAGEMENT, LLC 21,896 985,178 0.0%
CITADEL ADVISORS LLC 20,651 929,407 0.0%
Foresite Capital Management VI LLC 19,701 886,667 3.07%